HC Wainwright & Co. Reiterates Buy on Icecure Medical, Maintains $3 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Yi Chen has reiterated a Buy rating on Icecure Medical (NASDAQ:ICCM) and maintained a $3 price target.
May 23, 2023 | 10:15 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. analyst Yi Chen reiterated a Buy rating on Icecure Medical (NASDAQ:ICCM) and maintained a $3 price target.
The Buy rating and maintained $3 price target by HC Wainwright & Co. analyst Yi Chen indicates a positive outlook for Icecure Medical's stock. This news is likely to have a positive impact on the stock price in the short term as it shows confidence in the company's potential growth and performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100